Myasthenia Gravis, Generalized clinical trials at UC Health
1 research study open to eligible people
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
open to eligible people ages 18 years and up
Efficacy and safety of amifampridine phosphate in improving the activities of daily living for patients with antibody positive MuSK myasthenia gravis.
at UC Irvine
Last updated: